Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma

环磷酰胺动员可减少白细胞分离术产品中淋巴细胞亚群的数量,并延缓多发性骨髓瘤患者自体造血干细胞移植后淋巴细胞的重建。

阅读:1

Abstract

BACKGROUND: Autologous hematopoietic stem cell transplantation is considered the standard of care for younger patients with multiple myeloma. Several mobilization regimens are currently used, most commonly growth factors alone or in combination with chemotherapy. The aim of our study was to investigate the differences in lymphocyte subpopulation counts between three different mobilization regimens on collection day, in the leukapheresis product and on day 15 after autologous hematopoietic stem cell transplantation. PATIENTS AND METHODS: In total 48 patients were prospectively enrolled in three different mobilization regimens; (i) filgrastim (20), (ii) pegfilgrastim (19) and (iii) cyclophosphamide + filgrastim (9). Lymphocytes, CD16+/56+ natural killer and CD4+/CD25(high) T regulatory cells were determined by flow cytometry. RESULTS: We found a statistically significant difference between the mobilization regimens. Cyclophosphamide reduced lymphocyte and natural killer (NK) cell counts on collection day (lymphocytes 1.08 × 10(9)/L; NK cells 0.07 × 10(9)/L) compared to filgrastim (lymphocytes 3.08 × 10(9)/L; NK cells 0.52 × 10(9)/L) and pegfilgrastim (lymphocytes 3 × 10(9)/L; NK cells 0.42 × 10(9)/L). As a consequence lymphocyte and NK cell counts were also lower in the leukapheresis products following cyclophosphamide mobilization regimen (lymphocytes 50.1 × 10(9)/L; NK cells 4.18 × 10(9)/L) compared to filgrastim (lymphocytes 112 × 10(9)/L; NK cells 17.5 × 10(9)/L) and pegfilgrastim (lymphocytes 112 × 10(9)/L; NK cells 14.3 × 10(9)/L). In all mobilization regimens T regulatory cells increased 2-fold on collection day, regarding the base line value before mobilization. There was no difference in T regulatory cell counts between the regimens. CONCLUSIONS: Mobilization with cyclophophamide reduces the number of mobilized and collected lymphocytes and NK cells as compared to mobilization with growth factors only and results in their delayed reconstitution following autologous hematopoietic stem cell transplantation. We found no difference between filgrastim and pegfilgrastim mobilization.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。